ursodiol
Selected indexed studies
- Ursodiol for hepatobiliary disorders. (Ann Intern Med, 1994) [PMID:8017748]
- Ursodiol in patients with parenteral nutrition-associated cholestasis. (Ann Pharmacother, 2007) [PMID:17911205]
- ALSUntangled no. 25: ursodiol. (Amyotroph Lateral Scler Frontotemporal Degener, 2014) [PMID:24972316]
_Worker-drafted node — pending editorial review._
Connections
ursodiol is a side effect of
Sources
- Stability of Compounded Ursodiol Suspensions in PCCA Base, SuspendIt. (2019) pubmed
- Ursodiol for hepatobiliary disorders. (1994) pubmed
- Ursodiol in patients with parenteral nutrition-associated cholestasis. (2007) pubmed
- ALSUntangled no. 25: ursodiol. (2014) pubmed
- Ursodiol Prescriptions Following Bariatric Surgery: National Prescribing Trends and Outcomes. (2023) pubmed
- Ursodiol: good drug makes good. (2003) pubmed
- Ursodiol to prevent hepatic venoocclusive disease. (1997) pubmed
- Ursodiol: a cholesterol gallstone solubilizing agent. (1988) pubmed
- Ursodiol and colorectal cancer or dysplasia risk in primary sclerosing cholangitis and inflammatory bowel disease: a meta-analysis. (2013) pubmed
- Impact of Ursodiol on Number of Cholecystectomies Performed After Bariatric Surgery. (2025) pubmed